Global Oxcarbazepine Market Research Report 2021

Publisher Name :
Date: 25-Feb-2021
No. of pages: 131
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Tablets (150mg, 300mg, 600mg)

- Oral Suspension

Segment by Application

- Pediatric Use (Aged 2-4 years, 4-16 years)

- Adult Use

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Novartis (Trileptal)

- Supernus Pharmaceuticals (Oxtellar XR)

- Sun Pharm

- Ranbaxy Pharmaceuticals

- Jubilant Generics

- Taro Pharmaceuticals

- Mylan

- Stada Group

- Glenmark Pharmaceuticals

- ANI Pharmaceuticals

- Teva Pharmaceutical

- Roxane Laboratories

- Nobelpharma

- Apotex

- Nexgen pharma

- Amneal Pharmaceuticals

- Hikma Pharmaceuticals

- Jamp Pharma

- Neuraxpharm

- Orion Corporation

- Sihuan Pharm

- Humanwell Healthcare

- Huikang Pharmaceutical

Global Oxcarbazepine Market Research Report 2021

Table of Contents
1 Oxcarbazepine Market Overview
1.1 Product Overview and Scope of Oxcarbazepine
1.2 Oxcarbazepine Segment by Type
1.2.1 Global Oxcarbazepine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Tablets (150mg, 300mg, 600mg)
1.2.3 Oral Suspension
1.3 Oxcarbazepine Segment by Application
1.3.1 Oxcarbazepine Sales Comparison by Application: (2021-2027)
1.3.2 Pediatric Use (Aged 2-4 years, 4-16 years)
1.3.3 Adult Use
1.4 Global Oxcarbazepine Market Size Estimates and Forecasts
1.4.1 Global Oxcarbazepine Revenue 2016-2027
1.4.2 Global Oxcarbazepine Sales 2016-2027
1.4.3 Oxcarbazepine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Oxcarbazepine Market Competition by Manufacturers
2.1 Global Oxcarbazepine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Oxcarbazepine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Oxcarbazepine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Oxcarbazepine Manufacturing Sites, Area Served, Product Type
2.5 Oxcarbazepine Market Competitive Situation and Trends
2.5.1 Oxcarbazepine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oxcarbazepine Players Market Share by Revenue
2.5.3 Global Oxcarbazepine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oxcarbazepine Retrospective Market Scenario by Region
3.1 Global Oxcarbazepine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Oxcarbazepine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Oxcarbazepine Market Facts & Figures by Country
3.3.1 North America Oxcarbazepine Sales by Country
3.3.2 North America Oxcarbazepine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oxcarbazepine Market Facts & Figures by Country
3.4.1 Europe Oxcarbazepine Sales by Country
3.4.2 Europe Oxcarbazepine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oxcarbazepine Market Facts & Figures by Region
3.5.1 Asia Pacific Oxcarbazepine Sales by Region
3.5.2 Asia Pacific Oxcarbazepine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oxcarbazepine Market Facts & Figures by Country
3.6.1 Latin America Oxcarbazepine Sales by Country
3.6.2 Latin America Oxcarbazepine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oxcarbazepine Market Facts & Figures by Country
3.7.1 Middle East and Africa Oxcarbazepine Sales by Country
3.7.2 Middle East and Africa Oxcarbazepine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Oxcarbazepine Historic Market Analysis by Type
4.1 Global Oxcarbazepine Sales Market Share by Type (2016-2021)
4.2 Global Oxcarbazepine Revenue Market Share by Type (2016-2021)
4.3 Global Oxcarbazepine Price by Type (2016-2021)
5 Global Oxcarbazepine Historic Market Analysis by Application
5.1 Global Oxcarbazepine Sales Market Share by Application (2016-2021)
5.2 Global Oxcarbazepine Revenue Market Share by Application (2016-2021)
5.3 Global Oxcarbazepine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis (Trileptal)
6.1.1 Novartis (Trileptal) Corporation Information
6.1.2 Novartis (Trileptal) Description and Business Overview
6.1.3 Novartis (Trileptal) Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis (Trileptal) Product Portfolio
6.1.5 Novartis (Trileptal) Recent Developments/Updates
6.2 Supernus Pharmaceuticals (Oxtellar XR)
6.2.1 Supernus Pharmaceuticals (Oxtellar XR) Corporation Information
6.2.2 Supernus Pharmaceuticals (Oxtellar XR) Description and Business Overview
6.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Supernus Pharmaceuticals (Oxtellar XR) Product Portfolio
6.2.5 Supernus Pharmaceuticals (Oxtellar XR) Recent Developments/Updates
6.3 Sun Pharm
6.3.1 Sun Pharm Corporation Information
6.3.2 Sun Pharm Description and Business Overview
6.3.3 Sun Pharm Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sun Pharm Product Portfolio
6.3.5 Sun Pharm Recent Developments/Updates
6.4 Ranbaxy Pharmaceuticals
6.4.1 Ranbaxy Pharmaceuticals Corporation Information
6.4.2 Ranbaxy Pharmaceuticals Description and Business Overview
6.4.3 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ranbaxy Pharmaceuticals Product Portfolio
6.4.5 Ranbaxy Pharmaceuticals Recent Developments/Updates
6.5 Jubilant Generics
6.5.1 Jubilant Generics Corporation Information
6.5.2 Jubilant Generics Description and Business Overview
6.5.3 Jubilant Generics Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Jubilant Generics Product Portfolio
6.5.5 Jubilant Generics Recent Developments/Updates
6.6 Taro Pharmaceuticals
6.6.1 Taro Pharmaceuticals Corporation Information
6.6.2 Taro Pharmaceuticals Description and Business Overview
6.6.3 Taro Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Taro Pharmaceuticals Product Portfolio
6.6.5 Taro Pharmaceuticals Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Stada Group
6.8.1 Stada Group Corporation Information
6.8.2 Stada Group Description and Business Overview
6.8.3 Stada Group Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Stada Group Product Portfolio
6.8.5 Stada Group Recent Developments/Updates
6.9 Glenmark Pharmaceuticals
6.9.1 Glenmark Pharmaceuticals Corporation Information
6.9.2 Glenmark Pharmaceuticals Description and Business Overview
6.9.3 Glenmark Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Glenmark Pharmaceuticals Product Portfolio
6.9.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.10 ANI Pharmaceuticals
6.10.1 ANI Pharmaceuticals Corporation Information
6.10.2 ANI Pharmaceuticals Description and Business Overview
6.10.3 ANI Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 ANI Pharmaceuticals Product Portfolio
6.10.5 ANI Pharmaceuticals Recent Developments/Updates
6.11 Teva Pharmaceutical
6.11.1 Teva Pharmaceutical Corporation Information
6.11.2 Teva Pharmaceutical Oxcarbazepine Description and Business Overview
6.11.3 Teva Pharmaceutical Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Teva Pharmaceutical Product Portfolio
6.11.5 Teva Pharmaceutical Recent Developments/Updates
6.12 Roxane Laboratories
6.12.1 Roxane Laboratories Corporation Information
6.12.2 Roxane Laboratories Oxcarbazepine Description and Business Overview
6.12.3 Roxane Laboratories Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Roxane Laboratories Product Portfolio
6.12.5 Roxane Laboratories Recent Developments/Updates
6.13 Nobelpharma
6.13.1 Nobelpharma Corporation Information
6.13.2 Nobelpharma Oxcarbazepine Description and Business Overview
6.13.3 Nobelpharma Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Nobelpharma Product Portfolio
6.13.5 Nobelpharma Recent Developments/Updates
6.14 Apotex
6.14.1 Apotex Corporation Information
6.14.2 Apotex Oxcarbazepine Description and Business Overview
6.14.3 Apotex Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Apotex Product Portfolio
6.14.5 Apotex Recent Developments/Updates
6.15 Nexgen pharma
6.15.1 Nexgen pharma Corporation Information
6.15.2 Nexgen pharma Oxcarbazepine Description and Business Overview
6.15.3 Nexgen pharma Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Nexgen pharma Product Portfolio
6.15.5 Nexgen pharma Recent Developments/Updates
6.16 Amneal Pharmaceuticals
6.16.1 Amneal Pharmaceuticals Corporation Information
6.16.2 Amneal Pharmaceuticals Oxcarbazepine Description and Business Overview
6.16.3 Amneal Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Amneal Pharmaceuticals Product Portfolio
6.16.5 Amneal Pharmaceuticals Recent Developments/Updates
6.17 Hikma Pharmaceuticals
6.17.1 Hikma Pharmaceuticals Corporation Information
6.17.2 Hikma Pharmaceuticals Oxcarbazepine Description and Business Overview
6.17.3 Hikma Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Hikma Pharmaceuticals Product Portfolio
6.17.5 Hikma Pharmaceuticals Recent Developments/Updates
6.18 Jamp Pharma
6.18.1 Jamp Pharma Corporation Information
6.18.2 Jamp Pharma Oxcarbazepine Description and Business Overview
6.18.3 Jamp Pharma Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Jamp Pharma Product Portfolio
6.18.5 Jamp Pharma Recent Developments/Updates
6.19 Neuraxpharm
6.19.1 Neuraxpharm Corporation Information
6.19.2 Neuraxpharm Oxcarbazepine Description and Business Overview
6.19.3 Neuraxpharm Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Neuraxpharm Product Portfolio
6.19.5 Neuraxpharm Recent Developments/Updates
6.20 Orion Corporation
6.20.1 Orion Corporation Corporation Information
6.20.2 Orion Corporation Oxcarbazepine Description and Business Overview
6.20.3 Orion Corporation Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Orion Corporation Product Portfolio
6.20.5 Orion Corporation Recent Developments/Updates
6.21 Sihuan Pharm
6.21.1 Sihuan Pharm Corporation Information
6.21.2 Sihuan Pharm Oxcarbazepine Description and Business Overview
6.21.3 Sihuan Pharm Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Sihuan Pharm Product Portfolio
6.21.5 Sihuan Pharm Recent Developments/Updates
6.22 Humanwell Healthcare
6.22.1 Humanwell Healthcare Corporation Information
6.22.2 Humanwell Healthcare Oxcarbazepine Description and Business Overview
6.22.3 Humanwell Healthcare Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Humanwell Healthcare Product Portfolio
6.22.5 Humanwell Healthcare Recent Developments/Updates
6.23 Huikang Pharmaceutical
6.23.1 Huikang Pharmaceutical Corporation Information
6.23.2 Huikang Pharmaceutical Oxcarbazepine Description and Business Overview
6.23.3 Huikang Pharmaceutical Oxcarbazepine Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Huikang Pharmaceutical Product Portfolio
6.23.5 Huikang Pharmaceutical Recent Developments/Updates
7 Oxcarbazepine Manufacturing Cost Analysis
7.1 Oxcarbazepine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oxcarbazepine
7.4 Oxcarbazepine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oxcarbazepine Distributors List
8.3 Oxcarbazepine Customers
9 Oxcarbazepine Market Dynamics
9.1 Oxcarbazepine Industry Trends
9.2 Oxcarbazepine Growth Drivers
9.3 Oxcarbazepine Market Challenges
9.4 Oxcarbazepine Market Restraints
10 Global Market Forecast
10.1 Oxcarbazepine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oxcarbazepine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Oxcarbazepine by Type (2022-2027)
10.2 Oxcarbazepine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oxcarbazepine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Oxcarbazepine by Application (2022-2027)
10.3 Oxcarbazepine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oxcarbazepine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Oxcarbazepine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Oxcarbazepine Sales (M Unit) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Oxcarbazepine Sales (M Unit) Comparison by Application (2021-2027)
Table 3. Global Oxcarbazepine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Oxcarbazepine Covered in This Study
Table 5. Global Oxcarbazepine Sales (M Unit) of Key Manufacturers (2016-2021)
Table 6. Global Oxcarbazepine Sales Share by Manufacturers (2016-2021)
Table 7. Global Oxcarbazepine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Oxcarbazepine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Oxcarbazepine Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Oxcarbazepine Manufacturing Sites and Area Served
Table 11. Manufacturers Oxcarbazepine Product Type
Table 12. Global Oxcarbazepine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oxcarbazepine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxcarbazepine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oxcarbazepine Sales by Region (2016-2021) & (M Unit)
Table 16. Global Oxcarbazepine Sales Market Share by Region (2016-2021)
Table 17. Global Oxcarbazepine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Oxcarbazepine Sales by Country (2016-2021) & (M Unit)
Table 19. North America Oxcarbazepine Sales Market Share by Country (2016-2021)
Table 20. North America Oxcarbazepine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Oxcarbazepine Revenue Market Share by Country (2016-2021)
Table 22. Europe Oxcarbazepine Sales by Country (2016-2021) & (M Unit)
Table 23. Europe Oxcarbazepine Sales Market Share by Country (2016-2021)
Table 24. Europe Oxcarbazepine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Oxcarbazepine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Oxcarbazepine Sales by Region (2016-2021) & (M Unit)
Table 27. Asia Pacific Oxcarbazepine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Oxcarbazepine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Oxcarbazepine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Oxcarbazepine Sales by Country (2016-2021) & (M Unit)
Table 31. Latin America Oxcarbazepine Sales Market Share by Country (2016-2021)
Table 32. Latin America Oxcarbazepine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Oxcarbazepine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Oxcarbazepine Sales by Country (2016-2021) & (M Unit)
Table 35. Middle East and Africa Oxcarbazepine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Oxcarbazepine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Oxcarbazepine Revenue Market Share by Country (2016-2021)
Table 38. Global Oxcarbazepine Sales (M Unit) by Type (2016-2021)
Table 39. Global Oxcarbazepine Sales Market Share by Type (2016-2021)
Table 40. Global Oxcarbazepine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Oxcarbazepine Revenue Share by Type (2016-2021)
Table 42. Global Oxcarbazepine Price (USD/Unit) by Type (2016-2021)
Table 43. Global Oxcarbazepine Sales (M Unit) by Application (2016-2021)
Table 44. Global Oxcarbazepine Sales Market Share by Application (2016-2021)
Table 45. Global Oxcarbazepine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Oxcarbazepine Revenue Share by Application (2016-2021)
Table 47. Global Oxcarbazepine Price (USD/Unit) by Application (2016-2021)
Table 48. Novartis (Trileptal) Corporation Information
Table 49. Novartis (Trileptal) Description and Business Overview
Table 50. Novartis (Trileptal) Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Novartis (Trileptal) Oxcarbazepine Product
Table 52. Novartis (Trileptal) Recent Developments/Updates
Table 53. Supernus Pharmaceuticals (Oxtellar XR) Corporation Information
Table 54. Supernus Pharmaceuticals (Oxtellar XR) Description and Business Overview
Table 55. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product
Table 57. Supernus Pharmaceuticals (Oxtellar XR) Recent Developments/Updates
Table 58. Sun Pharm Corporation Information
Table 59. Sun Pharm Description and Business Overview
Table 60. Sun Pharm Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Sun Pharm Oxcarbazepine Product
Table 62. Sun Pharm Recent Developments/Updates
Table 63. Ranbaxy Pharmaceuticals Corporation Information
Table 64. Ranbaxy Pharmaceuticals Description and Business Overview
Table 65. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Ranbaxy Pharmaceuticals Oxcarbazepine Product
Table 67. Ranbaxy Pharmaceuticals Recent Developments/Updates
Table 68. Jubilant Generics Corporation Information
Table 69. Jubilant Generics Description and Business Overview
Table 70. Jubilant Generics Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Jubilant Generics Oxcarbazepine Product
Table 72. Jubilant Generics Recent Developments/Updates
Table 73. Taro Pharmaceuticals Corporation Information
Table 74. Taro Pharmaceuticals Description and Business Overview
Table 75. Taro Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Taro Pharmaceuticals Oxcarbazepine Product
Table 77. Taro Pharmaceuticals Recent Developments/Updates
Table 78. Mylan Corporation Information
Table 79. Mylan Description and Business Overview
Table 80. Mylan Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Mylan Oxcarbazepine Product
Table 82. Mylan Recent Developments/Updates
Table 83. Stada Group Corporation Information
Table 84. Stada Group Description and Business Overview
Table 85. Stada Group Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Stada Group Oxcarbazepine Product
Table 87. Stada Group Recent Developments/Updates
Table 88. Glenmark Pharmaceuticals Corporation Information
Table 89. Glenmark Pharmaceuticals Description and Business Overview
Table 90. Glenmark Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Glenmark Pharmaceuticals Oxcarbazepine Product
Table 92. Glenmark Pharmaceuticals Recent Developments/Updates
Table 93. ANI Pharmaceuticals Corporation Information
Table 94. ANI Pharmaceuticals Description and Business Overview
Table 95. ANI Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. ANI Pharmaceuticals Oxcarbazepine Product
Table 97. ANI Pharmaceuticals Recent Developments/Updates
Table 98. Teva Pharmaceutical Corporation Information
Table 99. Teva Pharmaceutical Description and Business Overview
Table 100. Teva Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Teva Pharmaceutical Oxcarbazepine Product
Table 102. Teva Pharmaceutical Recent Developments/Updates
Table 103. Roxane Laboratories Corporation Information
Table 104. Roxane Laboratories Description and Business Overview
Table 105. Roxane Laboratories Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Roxane Laboratories Oxcarbazepine Product
Table 107. Roxane Laboratories Recent Developments/Updates
Table 108. Nobelpharma Corporation Information
Table 109. Nobelpharma Description and Business Overview
Table 110. Nobelpharma Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Nobelpharma Oxcarbazepine Product
Table 112. Nobelpharma Recent Developments/Updates
Table 113. Apotex Corporation Information
Table 114. Apotex Description and Business Overview
Table 115. Apotex Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Apotex Oxcarbazepine Product
Table 117. Apotex Recent Developments/Updates
Table 118. Nexgen pharma Corporation Information
Table 119. Nexgen pharma Description and Business Overview
Table 120. Nexgen pharma Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Nexgen pharma Oxcarbazepine Product
Table 122. Nexgen pharma Recent Developments/Updates
Table 123. Amneal Pharmaceuticals Corporation Information
Table 124. Amneal Pharmaceuticals Description and Business Overview
Table 125. Amneal Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Amneal Pharmaceuticals Oxcarbazepine Product
Table 127. Amneal Pharmaceuticals Recent Developments/Updates
Table 128. Hikma Pharmaceuticals Corporation Information
Table 129. Hikma Pharmaceuticals Description and Business Overview
Table 130. Hikma Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Hikma Pharmaceuticals Oxcarbazepine Product
Table 132. Hikma Pharmaceuticals Recent Developments/Updates
Table 133. Jamp Pharma Corporation Information
Table 134. Jamp Pharma Description and Business Overview
Table 135. Jamp Pharma Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Jamp Pharma Oxcarbazepine Product
Table 137. Jamp Pharma Recent Developments/Updates
Table 138. Neuraxpharm Corporation Information
Table 139. Neuraxpharm Description and Business Overview
Table 140. Neuraxpharm Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Neuraxpharm Oxcarbazepine Product
Table 142. Neuraxpharm Recent Developments/Updates
Table 143. Orion Corporation Corporation Information
Table 144. Orion Corporation Description and Business Overview
Table 145. Orion Corporation Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Orion Corporation Oxcarbazepine Product
Table 147. Orion Corporation Recent Developments/Updates
Table 148. Sihuan Pharm Corporation Information
Table 149. Sihuan Pharm Description and Business Overview
Table 150. Sihuan Pharm Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Sihuan Pharm Oxcarbazepine Product
Table 152. Sihuan Pharm Recent Developments/Updates
Table 153. Humanwell Healthcare Corporation Information
Table 154. Humanwell Healthcare Description and Business Overview
Table 155. Humanwell Healthcare Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. Humanwell Healthcare Oxcarbazepine Product
Table 157. Humanwell Healthcare Recent Developments/Updates
Table 158. Huikang Pharmaceutical Corporation Information
Table 159. Huikang Pharmaceutical Description and Business Overview
Table 160. Huikang Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 161. Huikang Pharmaceutical Oxcarbazepine Product
Table 162. Huikang Pharmaceutical Recent Developments/Updates
Table 163. Production Base and Market Concentration Rate of Raw Material
Table 164. Key Suppliers of Raw Materials
Table 165. Oxcarbazepine Distributors List
Table 166. Oxcarbazepine Customers List
Table 167. Oxcarbazepine Market Trends
Table 168. Oxcarbazepine Growth Drivers
Table 169. Oxcarbazepine Market Restraints
Table 170. Global Oxcarbazepine Sales Forecast by Type (2022-2027) & (M Unit)
Table 171. Global Oxcarbazepine Sales Market Share Forecast by Type (2022-2027)
Table 172. Global Oxcarbazepine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 173. Global Oxcarbazepine Revenue Market Share Forecast by Type (2022-2027)
Table 174. Global Oxcarbazepine Sales Forecast by Application (2022-2027) & (M Unit)
Table 175. Global Oxcarbazepine Sales Market Share Forecast by Application (2022-2027)
Table 176. Global Oxcarbazepine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 177. Global Oxcarbazepine Revenue Market Share Forecast by Application (2022-2027)
Table 178. Global Oxcarbazepine Sales Forecast by Region (2022-2027) & (M Unit)
Table 179. Global Oxcarbazepine Sales Market Share Forecast by Region (2022-2027)
Table 180. Global Oxcarbazepine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 181. Global Oxcarbazepine Revenue Market Share Forecast by Region (2022-2027)
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oxcarbazepine
Figure 2. Global Oxcarbazepine Market Share by Type in 2020 & 2027
Figure 3. Tablets (150mg, 300mg, 600mg) Product Picture
Figure 4. Oral Suspension Product Picture
Figure 5. Global Oxcarbazepine Market Share by Application in 2020 & 2027
Figure 6. Pediatric Use (Aged 2-4 years, 4-16 years)
Figure 7. Adult Use
Figure 8. Global Oxcarbazepine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Oxcarbazepine Market Size 2016-2027 (US$ Million)
Figure 10. Global Oxcarbazepine Sales 2016-2027 (M Unit)
Figure 11. Global Oxcarbazepine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Oxcarbazepine Sales Share by Manufacturers in 2020
Figure 13. Global Oxcarbazepine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Oxcarbazepine Players: Market Share by Revenue in 2020
Figure 15. Oxcarbazepine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Oxcarbazepine Sales Market Share by Region (2016-2021)
Figure 17. Global Oxcarbazepine Sales Market Share by Region in 2020
Figure 18. Global Oxcarbazepine Revenue Market Share by Region (2016-2021)
Figure 19. Global Oxcarbazepine Revenue Market Share by Region in 2020
Figure 20. U.S. Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Oxcarbazepine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Oxcarbazepine by Type (2016-2021)
Figure 45. Sales Market Share of Oxcarbazepine by Application (2016-2021)
Figure 46. Sales Market Share of Oxcarbazepine by Application in 2020
Figure 47. Revenue Share of Oxcarbazepine by Application (2016-2021)
Figure 48. Revenue Share of Oxcarbazepine by Application in 2020
Figure 49. Manufacturing Cost Structure of Oxcarbazepine
Figure 50. Manufacturing Process Analysis of Oxcarbazepine
Figure 51. Oxcarbazepine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
  • Post-pandemic Era - Global Codeine Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 114
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Codeine Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 112
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Codeine Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 97
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Codeine growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions i......
  • Post-pandemic Era - Global Haloperidol Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 102
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Haloperidol Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 104
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Haloperidol Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 85
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Haloperidol growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regio......
  • Global Olanzapine Sales Market Report 2021
    Published: 07-Apr-2021        Price: US 4000 Onwards        Pages: 144
    The global Olanzapine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Olanzapine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Patent - Generics Segment by Application......
  • 2020-2025 Global Codeine Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 25-Mar-2021        Price: US 3360 Onwards        Pages: 99
    This report elaborates the market size, market characteristics, and market growth of the Codeine industry, and breaks down according to the type, application, and consumption area of Codeine. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendation......
  • Global Quetiapine Fumarate Market Growth 2021-2026
    Published: 23-Mar-2021        Price: US 3660 Onwards        Pages: 158
    According to this latest study, the 2021 growth of Quetiapine Fumarate will have significant change from previous year. By the most conservative estimates of global Quetiapine Fumarate market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 159.7 million in 2020. Over the next five years the Quetiapine Fumarate market will register a -2.3% CAGR in terms of revenue, the global market size will reach US$ 145.7 million by 2026. This rep......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs